COMMUNIQUÉS West-GlobeNewswire

-
ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware
01/07/2025 -
Fred Meyer and Washington State Collaborate to Provide Free Locking Bags to Prevent Opioid Misuse
01/07/2025 -
Processa Pharmaceuticals Provides Portfolio and Business Update
01/07/2025 -
Visory Health Wins Gold at the 2025 Digital Health Awards
01/07/2025 -
Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis
01/07/2025 -
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
01/07/2025 -
LiveWorld Releases First-Ever AI Brand Reputation Index for Leading OTC Brands
01/07/2025 -
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology
01/07/2025 -
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
01/07/2025 -
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
01/07/2025 -
VigRX Plus: Exploring the Science and Safety Behind a Popular VigRX Plus Natural Over the Counter Male Enhancement Supplement
01/07/2025 -
BioNTX Expands 2025 Tech Transfer Showcase to Spotlight Regional Innovation and Collaboration
01/07/2025 -
Foundation for Sarcoidosis Research Announces Launch of Enhanced Sarcoidosis Data Registry
01/07/2025 -
Dogecoin Cash Inc. (OTCQB: DOGP) Forms Dogecoin Treasury, Inc. to Support Development of Dogecoin-Related Tools and Infrastructure
01/07/2025 -
Bespoke Extracts, Inc. Announces Financial Results and Strategic Rebranding for the First Quarter Ended March 31, 2025
01/07/2025 -
Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Voden Medical Instruments Spa en Italie
01/07/2025 -
Eurobio Scientific completes the acquisition of Life Science unit of Voden Medical Instruments Spa in Italy
01/07/2025 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2025
01/07/2025 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2025
01/07/2025
Pages